D.E. Shaw & Co
NBP

D.E. Shaw & Co’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

D.E. Shaw & Co’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-50,000
Closed -$565K – 5339
2022
Q2 		$565K Buy
+50,000
New +$599K ﹤0.01% 4023

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co's NBP Position: Q2 2023 in Review

D.E. Shaw & Co sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2023, closing a stake of 17,266 shares — an estimated $59.7K sold.

D.E. Shaw & Co first reported a position in NBP in Q1 2021 and held it in 9 quarters. The position peaked at $16M in Q3 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q2 2023.

  • D.E. Shaw & Co reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 17,266 NovaBridge Biosciences American Depositary Shares shares in Q2 2023, an estimated $59.7K.
  • D.E. Shaw & Co first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2021 and held it in 9 quarters.
  • D.E. Shaw & Co's NovaBridge Biosciences American Depositary Shares position peaked at $16M in Q3 2021.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2023.

Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.